|
|
|
| Research progress and application evaluation of markers for acute kidney injury |
| LIU Yadong XING Yanfang |
| Ecsomatics Section, Department of Cardiovascular Disease, Yan'an University Affiliated Hospital, Shaanxi Province, Yan′an 716000, China |
|
|
|
Abstract When the markers of acute kidney injury (AKI) are abnormal, the kidney often has micromorphology and histological changes, which seriously affect the prognosis of the patients. In this paper, the biological markers of human neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, cystine inhibitor C, interleukin-18, N-acetyl-beta-D glucosaminidase, liver fatty acid binding protein and insulin like growth factor binding protein-7 are reviewed in order to provide a clinical basis for the early diagnosis, development and prognosis of AKI.
|
|
|
|
|
|
[1] 龙盘，何丽洁.急性肾损伤生物学标记物的研究进[J].山东医药，2016，56（9）：94-95.
[2] Khwaja A. KDIGO clinical practice guidelines for acute kidney injury [J]. Nephron Clin Pract，2012，120（4）：c179-c184.
[3] 许戎.血肌酐与胱抑素C对慢性肾脏病患者诊断及预后评估的临床价值[J].中华检验医学杂志，2014，37（6）：415-419.
[4] Cruz DN，Bagshaw SM，Maisel A，et al. Use of biomarkers to assessprognosis and guide management of patients with acute kidneyinjury [J]. Contrib Nephrol，2013，182：45-64.
[5] 王霞，王金泉.急性肾脏损伤生物标记物的作用机制及潜在治疗意义[J].医学研究生学报，2015，28（3）：318-322.
[6] Matsui K，Kamijo-Ikemori A，Hara M，et al. Clinical significanceof tubular and podocyte biomarkers in acute kidney injury [J]. Clin Exp Nephrol，2011，15（2）：220-225.
[7] 张雅丽，崔丽艳，张捷，等.中性粒细胞明胶酶相关脂质运载蛋白在急性肾损伤中的保护作用[J].检验医学，2015， 30（1）：80-84.
[8] Uettwillergeiger DL，Vijayendran R，Kellum JA，et al. Analytical characteristics of a biomarker-based risk assessment test for acute kidney injury（AKI）[J]. Chim Acta，2016，455（1）：93-98.
[9] Ferguson MA，Vaidya VS，Bonventre JV. Biomarkers of nep-hrotoxic acute kidney injury [J]. Toxicology，2008，245（3）：182-193.
[10] Geus HR，Woo JG，Wang Y，et al. Urinary neutrophil gelatinase-associated lipocalin measured on admission to the intensive care unit accurately discriminates between sustained and transient acute kidney injury in adult critically ill patients [J]. Nephron Extra，2011，1（1）：9-23.
[11] Eugeni AS，Antje E，Saban E，et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes [J]. Kidney Int，2011，80（4）：405-414.
[12] Gharishvandi F，Kazerouni F，Ghanei E，et al. Comparative assessment of neutrophil gelatinase-associated lipocalin（NGAL）and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension [J]. Iran Biomed J，2015，19（2）：76-81.
[13] Hur M，Kim H，Lee S，et al. Diagnostic and prognostic utilities of multimarkers approach using procalcitonin，B-type natriuretic peptide，andneutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis [J]. BMC Infect Dis，2014，14（1）：224.
[14] Vanmassenhove J，Glorieux G，Lameire N，et al. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acutekidney injury：a prospective cohort study of patients with sepsis [J]. BMC Nephrol，2015，16（1）：18.
[15] Nejat M，Pickering JM，Devarajan P，et al. Some biomarkers of acute kidney injury are incyeased in pre-renal acute injury [J]. Kidney Int，2012，81（12）：1254-1262.
[16] 王刘伟，董吉，房豫东．肾损伤分子１对高糖诱导大鼠肾小管上皮细胞表达单核细胞趋化蛋白１和纤维连接蛋白的影响[J].中华肿瘤防治杂志，2014，30（1）：48-52.
[17] Funk JA，Schnellmann RG. Persistent disruption of mitochondrial homeostasis after acute kidney injury [J]. Am J Physiol Renal Physiol，2012，302（7）：F853-F864.
[18] 张知，舒峤，廖跃华.尿液胱抑素C与B-N-乙酰氨基葡萄糖苷酶联合检测对肾小管损伤的诊断价值[J].国际检验医学杂志，2014，35（22）：3053-3054.
[19] Uslu S，Efe B，Alata So，et al. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic pafients [J]. J Nephrol，2005，18（5）：559-567.
[20] Noraddin FH，Flodin M，Fredricsson A，et al. Measurement of urinary cystain C with aparticle-enhanced turbidimetric immunoassay on Architect ci8200 [J]. J Clin Lab Anal，2012，26（5）：358-364.
[21] Song S，Meye MR，Turk T，et al. Serum cystatin C in mouse models：a reliable and precise marker for renal function and superior to serum creatinine [J]. Nephrol Dial Transpl，2009，24（4）：1157-1161.
[22] Jung YJ，Lee HR，Kwon OJ. Comparison of serum eystatin C and creatinine as a marker for early detection of decreasing glomemlar filtration rate in renal transplants [J]. J Korean Surg Soc，2012，83（2）：69-74.
[23] Zhang Z，Lu B，Sheng X，et al. Cystatin C in prediction of acute kidney injury：a systemic review and meta-analysis [J]. Am J Kidney Dis，2011，58（3）：356-365.
[24] Herget-Rosenthal S，Metzger J，Albalat A，et al. Proteomic biomarkers for the early detection of acute kidney injury [J]. Prilozi，2012，33（1）：27-48.
[25] Arthur JM，Hill EG，Alge JL，et al. Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery [J]. Kidney Int，2014，85（2）：431-438.
[26] Vitushynska MV，Matiytsiv NP，Chernyk YI. Influence of tissue-specific superoxide dismutase gene expression in brain cells on Drosophila melanogaster sensitivity to oxidative stress and viability [J]. Cytol Genet，2015，49（2）：95-101.
[27] Pipelzadeh MH，Jalali A，Dezfulian AR，et al. A forward to optimization of antivenom therapy：An in vivo study upon the effectiveness of the antivenom againstearly and delayed nephrotoxicity induced by the venom of the Iranian scorpion Hemiscorpius lepturus in rat [J]. Toxicon，2015，100：13-19.
[28] Liangos O，Perianayagam MC，Vaidya VS，et al. Urinary N-acetyl-beta-（D）-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure [J]. J Am Soc Nephrol，2007， 18（3）：904-912.
[29] Manabe K，Kamihata H，Motohiro M，et al. Urinary liver-type fattyacid-binding protein level as a predictive biomarker of contrastinducedacute kidney injury [J]. Eur J Clin Invest，2012，42（5）：557-563.
[30] Manabe K，Kamihata H，Motohiro M，et al. Urinary livertype fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury [J]. Eur J Clin Invest，2012，42（5）：557-563.
[31] Yang J，Choi HM，Seo MY，et al. Urine liver-type fatty acid?binding protein predicts graft outcome up to 2 years after kidney transplantation [J]. Transplant Proc，2014，46（2）：376-380.
[32] Parr SK，Clark AJ，Aihua B，et al. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury [J]. Kidney Int，2015，87（3）：640-648.
[33] Manabe K，Kamihata H，Motohiro M，et al. Urinary liver-typefatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury [J]. Eur J Clin Invest，2012，42（5）：557-563.
[34] Nakamura T，Sugaya T，Node K，et al． Urinary excretion of liver-type fatty acid-binding protein in contrast mediuminduced nephropathy [J]. Am J Kidney Dis，2006，47（3）：439-444.
[35] 唐荣，敖翔，钟永，等.尿L-FABP与尿NGAL联合应用在儿童心脏术后急性肾损伤早期诊断中的价值[J].中国当代儿科杂志，2017，19（7）：770-775.
[36] Peng ZY，Zhou F，Kellum JA. Cross-species validation of cell cycle arrest markers for acute kidney injury in the rat during sepsis [J]. Intensive Care Med Exp，2016，4（1）：1-8.
[37] Aydo?覿 Du M，Boyacl N，Yüksel S. A promising marker in early diagnosis of septic acute kidney injury of critically ill patients：urine insulin like growth factor binding protein-7 [J]. Scand J Clin Lab Invest，2016，76（5）：402-410.
[38] Kellum JA，Chawla LS. Cell-cycle arrest and acute kidney injury：the light and the dark sides [J]. Nephrol Dial Transplant，2016，31（1）：16-22.
[39] Aregger F，Uehlinger DE，Witowski J，et al. Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kideny injury [J]. Kindey Int，2014， 85（4）：909-919. |
|
|
|
